Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them.

Disparate recovery of cancer screenings by demographic in traditional Medicare post-pandemic. Distribution of clinical oncologists, oncology trials, and SDI index across selected African countries.

In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can help with reducing the burden of trial participation.

The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of ...

If the future of oncology research is to be inclusive, efficient, and representative, community-based clinical trials must be ...

What can Congress do to make clinical trials more accessible to patients? What are the biggest barriers to participation? And what does this all mean for the future of drug development?

In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change ...

Medically reviewed by Gagandeep Brar, MD Decentralized clinical trials (DCTs) are clinical studies that take place outside of ...

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

People often reject trial participation because they ... more about them and if they are a good fit. Other barriers for people considering a clinical trial include eligibility and costs.